Abiopharma

New Form 8-K - ORAGENICS INC Filed: 2025-08-11 AccNo: 0001641172-25-022908 Size: 283 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Zymeworks Inc. Filed: 2025-08-11 AccNo: 0001193125-25-177505 Size: 468 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: …

Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study

Equillium - Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic

Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic

Safety Shot Announces Strategic Alliance with Bonk Founding Contributors, Initiating BONK Treasury Strategy

Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio™ Initiative

Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment

New Form 6-K - DR REDDYS LABORATORIES LTD Filed: 2025-08-11 AccNo: 0001575872-25-000530 Size: 93 KB

New Form SCHEDULE 13G - Viatris Inc Filed: 2025-08-11 AccNo: 0000093751-25-000502 Size: 8 KB

New Form 8-K - SONIDA SENIOR LIVING, INC. Filed: 2025-08-11 AccNo: 0001043000-25-000070 Size: 6 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 6-K - Evaxion A/S Filed: 2025-08-11 AccNo: 0001171843-25-005267 Size: 13 KB

New Form 10-Q - Theriva Biologics, Inc. Filed: 2025-08-11 AccNo: 0001410578-25-001654 Size: 7 MB

New Form 8-K - CervoMed Inc. Filed: 2025-08-11 AccNo: 0001437749-25-025814 Size: 300 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Sonida Senior Living Announces Second Quarter 2025 Results